Growth Metrics

bioAffinity Technologies (BIAF) Depreciation & Amortization - Total (2022 - 2025)

Historic Depreciation & Amortization - Total for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $44599.0.

  • bioAffinity Technologies' Depreciation & Amortization - Total rose 1019.72% to $44599.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $175636.0, marking a year-over-year decrease of 3854.8%. This contributed to the annual value of $162332.0 for FY2024, which is 3034.87% down from last year.
  • As of Q3 2025, bioAffinity Technologies' Depreciation & Amortization - Total stood at $44599.0, which was up 1019.72% from $44468.0 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Depreciation & Amortization - Total registered a high of $166284.0 during Q4 2023, and its lowest value of $800.0 during Q3 2022.
  • Its 4-year average for Depreciation & Amortization - Total is $42869.8, with a median of $40472.0 in 2024.
  • Per our database at Business Quant, bioAffinity Technologies' Depreciation & Amortization - Total soared by 553687.5% in 2023 and then tumbled by 7425.73% in 2024.
  • bioAffinity Technologies' Depreciation & Amortization - Total (Quarter) stood at $7282.0 in 2022, then surged by 2183.49% to $166284.0 in 2023, then plummeted by 74.26% to $42806.0 in 2024, then increased by 4.19% to $44599.0 in 2025.
  • Its Depreciation & Amortization - Total stands at $44599.0 for Q3 2025, versus $44468.0 for Q2 2025 and $43763.0 for Q1 2025.